Showing 33,421 - 33,440 results of 59,489 for search '(( 01 ((1 decrease) OR (a decrease)) ) OR ( 50 ((teer decrease) OR (nn decrease)) ))', query time: 1.40s Refine Results
  1. 33421
  2. 33422
  3. 33423
  4. 33424
  5. 33425

    LiCl administration shifts GC taste responses in the direction of a simple “good vs. bad” judgment. by Bradly T. Stone (13149987)

    Published 2022
    “…<p><b>(A)</b> The time course of average correlations (Spearman rank-correlation coefficient) between firing rates and known palatability shows the expected increase as responses reached the late epoch, but this rise reached a higher peak following LiCl (<i>n</i> = 174) than saline injection (<i>n</i> = 136, Kruskal–Wallis H-test, ** <i>p <</i> 0.01). …”
  6. 33426

    Data_Sheet_1_Microbial-Driven Butyrate Regulates Jejunal Homeostasis in Piglets During the Weaning Stage.docx by Xi Zhong (4678897)

    Published 2019
    “…We aimed to investigate whether jejunal microbial metabolite butyrate modulates the apoptosis/proliferation balance and immune response in piglets during the post-weaning period of the first 3 weeks of life. On the one hand, during the first week post-weaning, the relative abundances of the dominant bacterial families Erysipelotrichaceae (P < 0.01) and Lachnospiraceae (P < 0.01) were increased, which induced decreases in both butyrate production (P < 0.05) and its receptor (G-protein coupled receptor 43) expression (P < 0.01). …”
  7. 33427

    Cerebral artery geometry and nucleus count of the smooth muscle layer. by Éva Pál (4825437)

    Published 2018
    “…<p>(A) VDD significantly increased the wall thickness (* p<0.05, n = 10–11) as well as (B) the wall thickness / lumen diameter ratio (** p<0.01, n = 10–11). …”
  8. 33428
  9. 33429

    Image 9_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  10. 33430

    Image 6_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  11. 33431

    Image 10_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  12. 33432

    Image 3_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  13. 33433

    Image 8_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  14. 33434

    Image 7_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  15. 33435

    Image 4_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  16. 33436

    Image 5_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  17. 33437

    Image 2_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

    Published 2025
    “…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
  18. 33438

    Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model by Tatsuro Nishimura (2646928)

    Published 2019
    “…</p><p>Results</p><p>Four weeks after infusing BMSCs, a significant improvement was observed in the Vein group (n = 8) compared to outcome in the Control group (n = 10), along with a decrease in ICG t<sub>1/2</sub>. …”
  19. 33439
  20. 33440